Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.010 Biomarker group BEFREE Both CEA and CEN increased the chance of having mental health problems even after taking into account the effects of other forms of childhood abuse and neglect. 31821980 2020
Malignant neoplasm of colon stage IV
0.010 AlteredExpression disease BEFREE To evaluate whether the serum levels of CEA or CA19-9 concentration is a useful predictor of survival in patients with metastatic colon cancer (mCC). 31662542 2020
CUI: C0751956
Disease: Acute Cerebrovascular Accidents
Acute Cerebrovascular Accidents
0.010 Biomarker disease BEFREE CEA vs stent in patients with acute strokes: are they equally effective? 31603298 2020
CUI: C0007130
Disease: Mucinous Adenocarcinoma
Mucinous Adenocarcinoma
0.010 Biomarker disease BEFREE The nomogram based on multivariate logistic regression analysis showed that clinical T4 and N2 stages were the most significant independent clinical predictors for not achieving pCR, followed by mucinous adenocarcinoma and positive pre-treatment serum CEA results. 31263674 2019
CUI: C0011265
Disease: Presenile dementia
Presenile dementia
0.010 Biomarker disease BEFREE We searched the databases PubMed, MODEM, CEA and NHS for publications on the cost-consequence, -effectiveness, -utility or -benefit analysis of (hypothetical) interventions to reduce the risk of developing dementia for persons without dementia, and described the study characteristics. 29039976 2019
Diabetes Mellitus, Insulin-Dependent
0.010 Biomarker disease BEFREE Together, these data provide evidence that PSG-1 can be employed as an alternative dietary supplement to ameliorate T1DM. 31616874 2019
CUI: C0015967
Disease: Fever
Fever
0.010 AlteredExpression phenotype BEFREE Effect of preoperative infusion chemotherapy combined with hyperthermia on sPD-L1 and CEA levels and overall survival of elderly patients undergoing radical resection of lung cancer. 31128008 2019
CUI: C0022346
Disease: Icterus
Icterus
0.010 AlteredExpression phenotype BEFREE Multivariate analysis for all patients demonstrated that CEA level, cell differentiation, chemotherapy, and recurrence were independent prognostic factors.Patients with PACs in a non-jaundice stage at diagnosis showed more favorable clinicopathological features and long-term survival than such patients with jaundice. 31702620 2019
CUI: C0022790
Disease: Krukenberg Tumor
Krukenberg Tumor
0.010 AlteredExpression disease BEFREE Peritoneal involvement, synchronous presentation, ascites and increased serum CEA levels appear as unfavorable prognostic factors in KT and might affect the patient management. 31542818 2019
CUI: C0023518
Disease: Leukocytosis
Leukocytosis
0.010 AlteredExpression phenotype BEFREE In multivariate analysis, CEA levels of >3 µg/L (P = 0.004, hazard ratio [HR] 1.89, 95% CI 1.22, 2.91), cholinesterase (CHE) levels of <5 kU/L (P = 0.001, HR 2.11, 95% CI 1.34, 3.31) and leukocytosis (P = 0.001, HR 2.90, 95% CI 1.51, 5.56) were associated with poor survival. 30716200 2019
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.010 AlteredExpression disease BEFREE Serum AFP, CEA, and CA19-9 levels in the PHC group were significantly higher compared to those with liver cirrhosis and healthy control groups (<i>P <</i> 0.03). 31205886 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 GeneticVariation disease BEFREE This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. 30827085 2019
CUI: C0030186
Disease: Paget Disease Extramammary
Paget Disease Extramammary
0.010 Biomarker disease BEFREE CEA and CYFRA 21-1 combination assays were positive in 95% of cases of metastatic EMPD.What is the translational message? 30791097 2019
CUI: C0030286
Disease: Pancreatic Diseases
Pancreatic Diseases
0.010 Biomarker group BEFREE Although the specificity of PhoSL-HP for NPDC was inferior to both of CA19-9 and CEA, that for pancreatic diseases was higher than both of CA19-9 and CEA. 31031206 2019
CUI: C0080032
Disease: Pleural Effusion, Malignant
Pleural Effusion, Malignant
0.010 Biomarker disease BEFREE For malignant effusion (ME) diagnosis, CEA and NGAL presented superior performance than VEGF-A, PD-L1 and CALP. 31310745 2019
CUI: C0149978
Disease: Adenocarcinoma of rectum
Adenocarcinoma of rectum
0.010 Biomarker disease BEFREE Inclusion criteria were patients having had a resection for either a colonic or upper third rectal adenocarcinoma and with a preoperative CEA value. 30822523 2019
CUI: C0221505
Disease: Lesion of brain
Lesion of brain
0.010 Biomarker group BEFREE This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. 30827085 2019
CUI: C0278480
Disease: Stage III Colon Cancer
Stage III Colon Cancer
0.010 Biomarker disease BEFREE For those with a history of stage III colon cancer, the optimal strategy was liver ultrasound and chest x-ray every 6 months with CEA measurement every 6 months. 31188189 2019
CUI: C0279628
Disease: Adenocarcinoma Of Esophagus
Adenocarcinoma Of Esophagus
0.010 Biomarker disease BEFREE Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma. 30724779 2019
CUI: C0497327
Disease: Dementia
Dementia
0.010 Biomarker disease BEFREE We searched the databases PubMed, MODEM, CEA and NHS for publications on the cost-consequence, -effectiveness, -utility or -benefit analysis of (hypothetical) interventions to reduce the risk of developing dementia for persons without dementia, and described the study characteristics. 29039976 2019
CUI: C0744869
Disease: Metastatic hepatocellular carcinoma
Metastatic hepatocellular carcinoma
0.010 AlteredExpression disease BEFREE The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. 31821607 2019
CUI: C0746102
Disease: Chronic lung disease
Chronic lung disease
0.010 Biomarker disease BEFREE CEA showed the highest AUC (0.849) to discriminate MHC group from CLD group. 31821607 2019
Lymphoproliferative Disorder of the Skin
0.010 Biomarker disease BEFREE CEA showed the highest AUC (0.849) to discriminate MHC group from CLD group. 31821607 2019
CUI: C1412036
Disease: Anal squamous cell carcinoma
Anal squamous cell carcinoma
0.010 Biomarker disease BEFREE Elevation of Serum CEA in Patients with Squamous Cell Carcinoma of the Anus. 31319725 2019
CUI: C1536222
Disease: Non STEMI
Non STEMI
0.010 GeneticVariation disease BEFREE This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. 30827085 2019